Core Insights - Nordson Corporation (NDSN) is positioned to benefit from its operational excellence, diversified business structure, and strategic acquisitions, focusing on growth opportunities to strengthen its market position [1] Business Performance - The company is experiencing a strong recovery in its Medical and Fluid Solutions segment, with organic sales increasing by 7.4% year over year in the fourth quarter of fiscal 2025 [2][8] - Demand for medical interventional products and fluid components is driving performance in the Medical segment, while the Advanced Technology Solutions segment benefits from healthy demand in electronic processing and optical sensors [3] Acquisition Impact - Nordson's acquisition of Atrion Corp in August 2024 has expanded its medical offerings, contributing to a 6% increase in total revenues for fiscal 2025 [4] Stock Performance - Over the past year, NDSN shares have increased by 14.8%, outperforming the industry growth of 7.3% [6] Shareholder Returns - The company is committed to enhancing shareholder value, having paid out $179.1 million in dividends (up 11% year over year) and repurchased $306.4 million in treasury shares in fiscal 2025 [6][9] - In August 2025, Nordson raised its dividend by 5% to 82 cents per share [9] Earnings Estimates - The Zacks Consensus Estimate for Nordson's fiscal 2026 earnings has risen from $10.94 to $11.19, with four upward revisions and no downward revisions [9]